A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a …
KM Zangwill, E Eriksen, M Lee, J Lee, SM Marcy… - …, 2008 - publications.aap.org
BACKGROUND. Prelicensure studies of diphtheria, tetanus, acellular pertussis, hepatitis B,
inactivated polio virus vaccine suggested that there were higher rates of fever after its …
inactivated polio virus vaccine suggested that there were higher rates of fever after its …
A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adults
M Van der Wielen, P Van Damme, E Joossens… - Vaccine, 2000 - Elsevier
The aim of this assessor-blinded trial was to compare the immunogenicity and reactogenicity
of a candidate diphtheria, tetanus toxoids and acellular pertussis vaccine with reduced …
of a candidate diphtheria, tetanus toxoids and acellular pertussis vaccine with reduced …
Waning immunity after receipt of pertussis, diphtheria, tetanus, and polio-related vaccines: a systematic review and meta-analysis
Pertussis, diphtheria, and tetanus (DTP)–containing vaccines combined with polio vaccines
are recommended by the World Health Organization as part of routine immunization …
are recommended by the World Health Organization as part of routine immunization …
Immunogenicity and reactogenicity of a single dose of a diphtheria–tetanus–acellular pertussis component vaccine (DTaP) compared to a diphtheria–tetanus toxoid …
I Bartels, J Jüngert, S Lugauer, K Stehr, U Heininger - Vaccine, 2001 - Elsevier
We compared immunogenicity and reactogenicity of a single dose of DTaP vaccine
(containing tetanus and diphtheria toxoids and four acellular pertussis antigens) with …
(containing tetanus and diphtheria toxoids and four acellular pertussis antigens) with …
The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a …
EA Talbot, KH Brown, KB Kirkland, AL Baughman… - Vaccine, 2010 - Elsevier
BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®) A Review of its Use as a Single-Dose Booster Immunization in …
GL Plosker - BioDrugs, 2009 - Springer
Boostrix® is a three-pertussis component, combined, reduced-antigen content tetanus,
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …
Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged≥ 65 years, Vaccine Adverse Event Reporting System …
P Haber, PL Moro, C Ng, GM Dores, S Perez-Vilar… - Vaccine, 2020 - Elsevier
Abstract Introduction The Advisory Committee on Immunization Practices (ACIP)
recommends vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular …
recommends vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular …
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose
SA Halperin, D Scheifele, G De Serres, F Noya… - Vaccine, 2012 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …
recommended in Canada and the United States, a second dose of pertussis vaccine during …
Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …
R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …
of booster doses in older children and adults. This can be conveniently accomplished by …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …